Get the Stockscreener App
8.35
11.48%
0.86
After Hours:
8.34
-0.010
-0.12%
Emergent Biosolutions Inc Stock (EBS) Forecast
The Emergent Biosolutions Inc (EBS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.31, representing a +71.36% increase from the current price of $8.35. The highest analyst price target is $14.63, and the lowest is $13.99.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EBS Price Target
Average 25.50
(+205.44% Upside)
Is Emergent Biosolutions Inc (EBS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 55.63 | Neutral |
| STOCH(9,6) | 46.07 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.4158 | Buy |
| ADX(14) | 15.64 | Neutral |
| William %R | 0.00 | Sell |
| CCI(14) | 123.36 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.855
Buy
|
7.1849
Buy
|
| MA20 |
7.2125
Buy
|
7.4249
Buy
|
| MA50 |
8.9402
Sell
|
7.9671
Buy
|
| MA100 |
7.8901
Buy
|
7.4266
Buy
|
| MA200 |
5.0954
Buy
|
6.4326
Buy
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, EBS could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 3 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on EBS, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 55.63 indicates that EBS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 46.07 indicates that EBS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that EBS is oversold. This suggests that EBS price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 15.64 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 123.36 indicates that EBS is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term EBS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Emergent Biosolutions Inc financial reports and earnings history, Emergent Biosolutions Inc (EBS) stock could reach $104.81 by 2030, $72.79 by 2040 and $370.25 by 2050. See the projected annual prices until 2050 of the Emergent Biosolutions Inc stock below:
- Emergent Biosolutions Inc (EBS) is expected to reach an average price of $234.41 in 2035, with a high prediction of $247.58 and a low estimate of $235.18. This indicates an $2,707% rise from the last recorded price of $8.35.
- Emergent Biosolutions Inc (EBS) stock is projected to chart a bullish course in 2040, with an average price target of $59.07, representing an $607.39% surge from its current level. The forecast ranges from a conservative $59.11 to a sky-high $72.79.
- Our analysts predict Emergent Biosolutions Inc (EBS) to jump 2,041% by 2045, soaring from $179.00 to an average price of $178.74, potentially reaching $198.61. While $179.00 is the low estimate, the potential upside is significant.
- Emergent Biosolutions Inc (EBS) stock is expected to climb by 2050, reaching an average of $347.34, a $4,060% jump from its current level. However, a wide range of estimates exists, with high and low targets of $370.25 and $347.40, respectively, highlighting the market's uncertainty.
Emergent Biosolutions Inc Stock (EBS) Year by Year Forecast
Emergent Biosolutions Inc Stock (EBS) Price Forecast for 2024
Our forecast for EBS stock price in 2024 now indicates an average price target of $11.10 with a high forecast of $21.13 and a low forecast of $1.07. The average prediction reflects an increase of +32.92% from the last recorded price of $8.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2024 | $13.79 | $13.99 | $14.63 | +65.11% |
| December, 2024 | $13.71 | $13.95 | $13.67 | +64.22% |
Emergent Biosolutions Inc Stock (EBS) Price Forecast for 2025
Emergent Biosolutions Inc Stock (EBS) is expected to reach an average price of $25.50 in 2025, with a high prediction of $50.65 and a low estimate of $0.3582. This indicates an +205.44% rise from the last recorded price of $8.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $12.21 | $12.71 | $13.32 | +46.29% |
| February, 2025 | $10.84 | $11.02 | $11.76 | +29.83% |
| March, 2025 | $8.8464 | $9.1064 | $10.11 | +5.94% |
| April, 2025 | $7.4386 | $7.4436 | $8.3928 | -10.91% |
| May, 2025 | $6.0444 | $6.0744 | $6.9951 | -27.61% |
| June, 2025 | $3.2602 | $3.1537 | $3.9408 | -60.96% |
| July, 2025 | $1.8224 | $1.8824 | $2.5666 | -78.17% |
| August, 2025 | $0.8485 | $0.3582 | $1.3388 | -89.84% |
| September, 2025 | $47.86 | $29.28 | $50.65 | +473.16% |
| October, 2025 | $45.12 | $45.59 | $46.71 | +440.40% |
| November, 2025 | $42.24 | $42.75 | $42.74 | +405.92% |
| December, 2025 | $39.29 | $39.17 | $41.38 | +370.53% |
Emergent Biosolutions Inc Stock (EBS) Price Forecast for 2026
The predicted value for Emergent Biosolutions Inc (EBS) in 2026 is set at an average of $29.81. Estimates vary from a peak of $57.04 to a trough of $2.5863, indicating an +257.04% surge from the present price of $8.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $36.55 | $36.61 | $38.11 | +337.73% |
| February, 2026 | $35.05 | $34.65 | $35.52 | +319.79% |
| March, 2026 | $32.14 | $32.55 | $34.23 | +284.95% |
| April, 2026 | $30.06 | $30.10 | $31.21 | +259.98% |
| May, 2026 | $26.85 | $27.34 | $29.19 | +221.55% |
| June, 2026 | $23.82 | $24.00 | $25.98 | +185.28% |
| July, 2026 | $19.43 | $19.48 | $22.67 | +132.64% |
| August, 2026 | $16.70 | $16.70 | $18.24 | +99.97% |
| September, 2026 | $11.64 | $12.90 | $15.84 | +39.42% |
| October, 2026 | $8.6232 | $8.9532 | $9.9446 | +3.27% |
| November, 2026 | $5.7048 | $5.7648 | $7.6561 | -31.68% |
| December, 2026 | $58.77 | $2.5863 | $57.04 | +603.83% |
Emergent Biosolutions Inc Stock (EBS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Emergent Biosolutions Inc (EBS) is $52.52, with a high forecast of $80.17 and a low forecast of $24.87. This indicates an +528.98% increase from the last price of $8.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $75.53 | $76.62 | $80.17 | +804.52% |
| February, 2027 | $72.16 | $72.93 | $72.06 | +764.25% |
| March, 2027 | $66.68 | $66.76 | $69.00 | +698.58% |
| April, 2027 | $62.61 | $62.63 | $65.06 | +649.80% |
| May, 2027 | $58.22 | $58.28 | $61.02 | +597.20% |
| June, 2027 | $54.25 | $54.60 | $56.77 | +549.73% |
| July, 2027 | $49.86 | $50.02 | $52.13 | +497.12% |
| August, 2027 | $46.35 | $46.39 | $48.42 | +455.06% |
| September, 2027 | $40.66 | $40.78 | $45.07 | +386.99% |
| October, 2027 | $35.31 | $35.69 | $38.99 | +322.89% |
| November, 2027 | $30.34 | $30.39 | $33.80 | +263.34% |
| December, 2027 | $24.87 | $24.87 | $28.74 | +197.79% |
Emergent Biosolutions Inc Stock (EBS) Price Forecast for 2028
In 2028, Emergent Biosolutions Inc (EBS) is projected to reach an average price of $57.26, with a high projection of $109.71 and a low estimate of $4.8145. This indicates an +585.75% rise from the last price of $8.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $18.83 | $20.09 | $23.53 | +125.54% |
| February, 2028 | $14.16 | $14.49 | $16.72 | +69.58% |
| March, 2028 | $8.3665 | $8.5864 | $12.78 | +0.20% |
| April, 2028 | $89.12 | $4.8145 | $87.39 | +967.31% |
| May, 2028 | $101.28 | $102.16 | $109.71 | +1,113% |
| June, 2028 | $97.33 | $98.18 | $99.50 | +1,066% |
| July, 2028 | $91.66 | $91.74 | $95.17 | +997.67% |
| August, 2028 | $84.58 | $84.85 | $89.62 | +912.98% |
| September, 2028 | $78.13 | $78.26 | $82.32 | +835.65% |
| October, 2028 | $73.85 | $74.20 | $75.14 | +784.43% |
| November, 2028 | $66.86 | $66.92 | $71.32 | +700.71% |
| December, 2028 | $61.29 | $61.34 | $65.01 | +634.04% |
Emergent Biosolutions Inc Stock (EBS) Price Forecast for 2029
The 2029 price forecast for Emergent Biosolutions Inc Stock (EBS) is $73.34 on average, with a high prediction of $139.64 and a low estimate of $7.0427. This represents an +778.35% increase from the previous price of $8.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $53.18 | $53.42 | $59.57 | +536.90% |
| February, 2029 | $46.12 | $46.30 | $51.40 | +452.38% |
| March, 2029 | $39.80 | $39.80 | $44.24 | +376.61% |
| April, 2029 | $33.71 | $33.71 | $38.00 | +303.72% |
| May, 2029 | $23.88 | $24.37 | $31.97 | +185.98% |
| June, 2029 | $18.08 | $18.12 | $21.88 | +116.55% |
| July, 2029 | $11.84 | $12.06 | $16.12 | +41.74% |
| August, 2029 | $141.56 | $7.0427 | $139.64 | +1,595% |
| September, 2029 | $129.56 | $130.44 | $139.22 | +1,452% |
| October, 2029 | $122.90 | $122.91 | $127.33 | +1,372% |
| November, 2029 | $114.55 | $115.05 | $119.83 | +1,272% |
| December, 2029 | $107.49 | $107.76 | $112.18 | +1,187% |
Emergent Biosolutions Inc Stock (EBS) Price Forecast for 2030
Emergent Biosolutions Inc Stock (EBS) is expected to reach an average price of $89.42 in 2030, with a high forecast of $169.58 and a low forecast of $9.2708. This signifies an +970.95% surge from the last price of $8.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $96.88 | $97.17 | $104.81 | +1,060% |
| February, 2030 | $91.23 | $91.91 | $94.60 | +992.57% |
| March, 2030 | $84.39 | $84.45 | $88.69 | +910.64% |
| April, 2030 | $77.17 | $77.22 | $82.13 | +824.16% |
| May, 2030 | $66.99 | $67.23 | $75.03 | +702.26% |
| June, 2030 | $58.28 | $58.46 | $64.79 | +597.94% |
| July, 2030 | $48.38 | $48.42 | $55.98 | +479.39% |
| August, 2030 | $40.54 | $40.60 | $46.27 | +385.48% |
| September, 2030 | $30.66 | $31.15 | $38.41 | +267.14% |
| October, 2030 | $21.02 | $21.12 | $28.25 | +151.71% |
| November, 2030 | $13.36 | $13.38 | $18.87 | +59.96% |
| December, 2030 | $171.50 | $9.2708 | $169.58 | +1,954% |
2.23%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):